| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 3 | |
| #2 | Australia | 1 | |
| #3 | Canada | 1 | |
| #4 | Czechia | 1 | |
| #5 | EPO (European Patent Office) | 1 | |
| #6 | Norway | 1 | |
| #7 | New Zealand | 1 | |
| #8 | Poland | 1 | |
| #9 | Slovakia | 1 | |
| #10 | WIPO (World Intellectual Property Organization) | 1 | |
| #11 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Loder Cari | 11 |
| Publication | Filing date | Title |
|---|---|---|
| AU3612695A | Treatment of multiple sclerosis (ms) and other demyelinating conditions using lofepramine in combination with l-phenylalanine, tyrosine or tryptophan and possibly a vitamin b12 compound | |
| GB9707065D0 | Treatment of multiple sclerosis (MS) and other demyelinating conditions | |
| GB9508482D0 | A therapeutic drug treatment for compensating for the effects of nerve damage caused by multiple sclerosis and other demyelinating conditions, and the product | |
| GB9420116D0 | A therapeutic drug treatment for compensating for the effects of nerve damage caused by multiple sclerosis and other demyelinating conditions |